Patents by Inventor Takashi K. Kishimoto

Takashi K. Kishimoto has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SACCHARIDE STRUCTURES AND METHODS OF MAKING AND USING SUCH STRUCTURES
    Publication number: 20140200339
    Abstract: Described are oligosaccharides having a protecting group at two, a plurality, a majority of, or each position in the oligosaccharide which is amenable to derivatization. Collections, libraries and methods of making and using such oligosaccharides are also described.
    Type: Application
    Filed: November 8, 2013
    Publication date: July 17, 2014
    Applicant: MOMENTA PHARMACEUTICALS, INC.
    Inventors: Sucharita Roy, Takashi K. Kishimoto, Ganesh Kaundinya
  • Combination anti-selectin and immunosuppressant therapy
    Publication number: 20020164336
    Abstract: A combination therapy of administering to a patient at least one selectin inhibitor and at least one immunosuppressant is employed in methods for modulating the patient's immune response, and in treatment regimens for organ and tissue transplant rejections and various inflammatory disorders. In some embodiments, the selectin inhibitor is an antibody to L-selectin or P-selectin such as a Dreg series of monoclonal antibody, or a functional fragment thereof, or SLex or a SLex derivative or mimetic, and the immunosuppressant is cyclosporin A.
    Type: Application
    Filed: May 8, 2002
    Publication date: November 7, 2002
    Inventors: Paul C. Harrison, Jeffrey B. Madwed, Robert Rothlein, Takashi K. Kishimoto
  • Methods for treating various disease states by reducing adhesion of leukocytes of target cells
    Patent number: 5948758
    Abstract: The invention relates to therapeutic methods of using a substantially pure protein comprising the .beta.-subunit of a human glycoprotein involved in cellular adhesion, or a biologically active fragment thereof, or analog thereof. These therapeutic methods are useful for treating auto immune diseases and allograft rejection.
    Type: Grant
    Filed: March 4, 1997
    Date of Patent: September 7, 1999
    Assignee: Dana Faber Cancer Institute Inc.
    Inventors: Timothy Springer, Takashi K. Kishimoto, Thomas M. Roberts
  • Cloning LFA-1
    Patent number: 5739032
    Abstract: The present invention discloses a cDNA sequence which encodes the beta-subunit of LFA-1. The present invention further discloses fragments of the cDNA sequence which are capable of recognizing a restriction length polymorphism within the LFA-1 sequence.
    Type: Grant
    Filed: April 6, 1994
    Date of Patent: April 14, 1998
    Assignee: Dana-Farber Cancer Institute, Inc.
    Inventors: Timothy Springer, Takashi K. Kishimoto, Thomas M. Roberts